K-W Peng

Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma

Angela Dispenzieri, Chin Voon Tong, Betsy LaPlant et al. · Leukemia · 2017 · 147 citations

Life Sciences, Biotechnology, Immunology +11

Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without Cyclophosphamide

Rae Myers, Suzanne Greiner, Mia Harvey et al. · Clinical Pharmacology & Therapeutics · 2007 · 127 citations · Full text

Medicine, Infectious Diseases, Pharmacology +14

Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies

Huy Ong, Kosei Hasegawa, Allan B. Dietz et al. · Gene Therapy · 2006 · 126 citations

Life Sciences, Immunology, Infectious Diseases +16

Curative one-shot systemic virotherapy in murine myeloma

Shruthi Naik, Rebecca A. Nace, Mark J. Federspiel et al. · Leukemia · 2012 · 83 citations · Full text

Medicine, Hematology, Oncology +8

Dynamics of multiple myeloma tumor therapy with a recombinant measles virus

David Dingli, Catherine A. Offord, Rae Myers et al. · Cancer Gene Therapy · 2009 · 73 citations · Full text

Medicine, Immunology, Oncology +13